Data / Form D filings / NeurogesX Inc
NeurogesX Inc: Form D filings
NeurogesX Inc, a pharmaceuticals company in San Mateo, CA, filed 5 Form D notices with the SEC between 2011 and 2012. The latest, on November 27, 2012, reports $684,300 sold of a $684,300 offering to 1 investor.
Find out what NeurogesX Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 999 Baker Way Suite 200, San Mateo, CA, 94404
- Phone
- (650) 358-3304
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1385830
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 27, 2012 | New notice | $684,300 | $684,300 | $0 | 1 | Nov 12, 2012 | sec.gov |
| Mar 29, 2012 | New notice | $975,000 | $975,000 | $0 | 1 | Mar 26, 2012 | sec.gov |
| Feb 8, 2012 | New notice | $2,999,382 | $2,999,382 | $0 | 6 | Feb 3, 2012 | sec.gov |
| Aug 17, 2011 | New notice | $1,425,000 | $1,425,000 | $0 | 1 | Aug 5, 2011 | sec.gov |
| Aug 3, 2011 | New notice | $20,209,229 | $20,209,229 | $0 | 29 | Jul 26, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary F. Lyons | Director | |
| Anthony F. DiTonno | Director | |
| John F. Orwin | Director | |
| Bradford F. Goodwin | Director | |
| Neil F. Kurtz | Director | |
| Steven F. Nelson | Director | |
| Stephen F. Ghiglieri | Executive Officer | |
| Robert F. Nelsen | Director | |
| Ronald A. Martell | Executive Officer, Director | |
| Stephen F. Peroutka | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Nov 26, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NeurogesX Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.